Global In-Vitro Fertilization Market Expected to Touch a Value of US$725.9 Mn by 2022

New research report offers a comprehensive analysis of the “In-Vitro Fertilization Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2022” The main objective of this report is to deliver insightful information and clear-cut facts pertaining to the growth trajectories of the market.

Request to view Sample Report @ https://www.mrrse.com/sample/3740

Global In-Vitro Fertilization Market: Overview

The rising rate of infertility among men and women in several developing and developed regions has led to the demand for in-vitro fertilization procedures.  A growing number of men and women who are infertile due to anatomic factors or chromosomal defects are finding favorable outcomes in IVF as assisted reproductive technologies. A number of improper lifestyle changes also have aggravated the problem of infertility, even after a year of unprotected intercourse between the couples. The growing awareness of male infertility among populations in the Middle East and Africa (MEA) and some parts of Europe has also catalyzed the demand for IVF treatments. In several developed countries, the use of IVF is gaining prominence among fertile couples who are suffering with genetic diseases but do not want to transfer the defects in their offspring. Recent advancements in IVF devices and reagent also augurs well for the market. The rise in medical tourism in some emerging economies is expected to unlock exciting opportunities in the coming years.

The global in-vitro fertilization market is projected to grow from US$529.8 Mn in 2017 to US$725.9 Mn by the end of 2022. The worldwide market is forecast to expand at a CAGR of 6.5% during 2017–2022.

APEJ Projected to be Most Lucrative Market

The major regional markets profiled in the report are North America, Latin America, Middle East and Africa, Europe, Asia Pacific excluding Japan (APEJ), and Japan. Of these, the APEJ holds the major revenue of the global market in 2017 and is expected to retain its dominance through the forecast timeline. Rising at a CAGR of 6.7% from 2017 to 2022, the APEJ in-vitro fertilization market will reach a worth US$235.9 Mn by the end of the forecast period. The dominance is attributed to favorable governmental initiatives and a burgeoning medical tourism in several emerging nations. The regional market will further benefit from players looking to capitalize on opportunities from unmet medical needs.

North America to Rise at Impressive Pace

The North America in-vitro fertilization market is projected to rise from US$141.3 Mn in 2017 to US$196.1 Mn by the end of 2022. The regional market is anticipated to rise at an impressive CAGR of 6.8% during 2017 - 2022. Constant advancements made in IVF technologies and growing insurance coverage are key factors accentuating the regional market. Furthermore, the growth is likely to be fueled by rising rate of infertility in the region.

Browse Full Report with TOC @ https://www.mrrse.com/in-vitro-fertilization-market

Meanwhile, Europe in-vitro fertilization market is projected to lose some 44 BPS from 2017 to 2022. By 2017 end, the global share of the regional market is estimated at 19.9%, vis-à-vis revenue. The MEA market is also estimated to lose 11 BPS in its market share from 2017 through 2022.

On the basis of product type, the report segments the in-vitro fertilization market into equipment, reagents, and others. Among these, the reagents holds the major share in the market. The estimated valuation of the segment is US$ 284.1 Mn in 2017, standing for 53.6% and is projected to rise to US$ 385.9 Mn by 2022 end. This will represent a share of 53.2%, an incremental decline in share. However, the annual growth of the segment in absolute terms is US$ 20.3 Mn, which is larger than all other segments. The segment is anticipated to register a CAGR of 6.3% during the forecast period.

Competitive Analysis

Some of prominent players operating in the market are Thermo Fisher Scientific, Inc., Cook Medical, Merck KGaA, Vitrolife AB, Ovascience, Inc., CooperSurgical, EMD Serono, Inc., Genea Ltd., Rocket Medical PLC, and Fertility Focus Ltd. These players are focused on launching advanced technologies that are likely to substantially improve the outcome of the IVF cycles. This will help them gain a competitive edge over others.

About (MRRSE)

Market Research Reports Search Engine (MRRSE) is an industry-leading database of Market Research Reports. MRRSE is driven by a stellar team of research experts and advisors trained to offer objective advice. Our sophisticated search algorithm returns results based on the report title, geographical region, publisher, or other keywords. 

MRRSE partners exclusively with leading global publishers to provide clients single-point access to top-of-the-line market research. MRRSE’s repository is updated every day to keep its clients ahead of the next new trend in market research, be it competitive intelligence, product or service trends or strategic consulting.

Contact Us                                                                         

State Tower                                                      
90, State Street
Suite 700
Albany, NY - 12207
United States Telephone: +1-518-730-0559
Email: sales@mrrse.com
Website: https://www.mrrse.com/
Read More Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.